INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 270 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,183,958 | -12.9% | 764,178 | -6.2% | 0.06% | -15.5% |
| Q2 2023 | $33,516,343 | +40.9% | 814,888 | +95.2% | 0.07% | +36.5% |
| Q1 2023 | $23,786,486 | -0.6% | 417,380 | -2.4% | 0.05% | -5.5% |
| Q4 2022 | $23,939,936 | +31.3% | 427,728 | -0.6% | 0.06% | +25.0% |
| Q3 2022 | $18,227,000 | +27.8% | 430,278 | +63.0% | 0.04% | +37.5% |
| Q2 2022 | $14,261,000 | +72.2% | 263,943 | +104.8% | 0.03% | +100.0% |
| Q1 2022 | $8,282,000 | +44.6% | 128,881 | +50.8% | 0.02% | +60.0% |
| Q4 2021 | $5,727,000 | +43.4% | 85,488 | +46.6% | 0.01% | +42.9% |
| Q3 2021 | $3,993,000 | -22.4% | 58,307 | -22.7% | 0.01% | -22.2% |
| Q2 2021 | $5,148,000 | -51.2% | 75,442 | -50.6% | 0.01% | -47.1% |
| Q1 2021 | $10,559,000 | -21.8% | 152,852 | -26.5% | 0.02% | -29.2% |
| Q4 2020 | $13,494,000 | +11.4% | 207,859 | -20.1% | 0.02% | +20.0% |
| Q3 2020 | $12,108,000 | +82.8% | 260,107 | +81.6% | 0.02% | +81.8% |
| Q2 2020 | $6,623,000 | +14.1% | 143,265 | +43.9% | 0.01% | +57.1% |
| Q4 2019 | $5,803,000 | +12.7% | 99,571 | +16.1% | 0.01% | +16.7% |
| Q3 2019 | $5,151,000 | +681.6% | 85,749 | +626.4% | 0.01% | +500.0% |
| Q2 2019 | $659,000 | +71.2% | 11,805 | +69.6% | 0.00% | – |
| Q1 2018 | $385,000 | +15.6% | 6,961 | 0.0% | 0.00% | – |
| Q4 2017 | $333,000 | -62.6% | 6,961 | -60.5% | 0.00% | -100.0% |
| Q3 2017 | $891,000 | -13.4% | 17,644 | -6.5% | 0.00% | 0.0% |
| Q2 2017 | $1,029,000 | -15.5% | 18,872 | -34.7% | 0.00% | -50.0% |
| Q1 2017 | $1,218,000 | -15.5% | 28,916 | +72.2% | 0.00% | 0.0% |
| Q4 2016 | $1,441,000 | -1.1% | 16,796 | -4.8% | 0.00% | 0.0% |
| Q3 2016 | $1,457,000 | +13.0% | 17,649 | +9.2% | 0.00% | 0.0% |
| Q2 2016 | $1,289,000 | +10.3% | 16,157 | -6.9% | 0.00% | 0.0% |
| Q1 2016 | $1,169,000 | -20.0% | 17,357 | -19.5% | 0.00% | -33.3% |
| Q4 2015 | $1,461,000 | +44.7% | 21,552 | +27.0% | 0.00% | +50.0% |
| Q3 2015 | $1,010,000 | +15.7% | 16,964 | +30.9% | 0.00% | 0.0% |
| Q2 2015 | $873,000 | +139.8% | 12,960 | +119.7% | 0.00% | +100.0% |
| Q1 2015 | $364,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |